Skip to content
All Updates
- DRAP finalized guidelines on Post Registration Variations of Pharmaceutical and Biological Drug ProductsNovember 27, 2022
- Drug Safety Alert: Risk of Reduced Vitamin B12 Level with Metformin and Metformin-Containing MedicinesNovember 25, 2022
- Drug Safety Alert: Risk of Severe Cutaneous Adverse Reactions (SCARs) with AtezolizumabNovember 25, 2022
- Stakeholder Comments are invited on the Draft Therapeutic Goods (Federal Inspectors, Laboratories and Federal Government Analysts) Rules, 2022November 24, 2022
- Drug Safety Update: Risk of Hypothyroidism in Babies and Young Children with Iodinated Contrast Media (ICM) InjectionsNovember 24, 2022
- DRAP invited Comments from Stakeholders on the Draft Therapeutic Goods (Advertisement) Rules, 2022November 22, 2022
- Drug Safety Update; PRAEC issued a Safety Alert on Risk of Sinus Bradycardia with RemdesivirNovember 21, 2022
- Drug Safety Update: Risk of Infusion-Related Hypersensitivity Reactions with RemdesivirNovember 18, 2022
- Drug Safety Alert: Risk of Serious Bowl complications with clozapineNovember 18, 2022
- Drug Safety Alert: Risk of Anaphylactic Reaction / Anaphylactic Shock with Diclofenac Sodium InjectionNovember 18, 2022
- Medicine Safety Week 2022; DRAP’s Call to Healthcare Professionals and Patients to Report Suspected Adverse Reactions of drugs and vaccines.November 14, 2022
- DRAP Signed MoU with Pakistan Single Window to Foster CooperationNovember 12, 2022
- Recall Alert: Drug Product; Moxtrex 400mg Tablets (Batch # 850) by M/s Gillman Pharmaceuticals, Hattar, Khyber PakhtunkhwaNovember 7, 2022
- Recall Alert: Drug Product; Ceficure 400mg Capsules (Batch # C-737) by M/s Max Pharmaceuticals IslamabadNovember 4, 2022
- Recall Alert: Drug Product; Telsarta 40mg Tablets (Batch # 2B151) by M/s PharmEvo Pharmaceuticals Pvt Ltd. KarachiNovember 4, 2022
- Expression of Interest from hospitals for medical treatmentNovember 4, 2022
- Notification – SRO 1995(I)/2022 MRP of ParacetamolNovember 4, 2022
- Minutes of 1st Meeting of Pharmacovigilance Risk Assessment Expert Committee (PRAEC) held on 12-October, 2022November 3, 2022
- Suspected Falsified Alert; Drug Products; Suspected Anti-D Immunoglobulin Injection in the marketOctober 31, 2022
- Regulatory Update / Advisory; Recall of Targocid 200mg powder for solution for injection/infusion or oral solution in UKOctober 31, 2022
- Decisions of 50th meeting of Medial Device Board (Deficiency letters Local/Import)October 28, 2022
- DRAP finalizes Guidelines on the Preparation of Summary of Product Characteristics (SmPC)October 27, 2022
- Minutes of 321st meeting of Registration Board held on 20th to 22nd September, 2022October 26, 2022
- Suspected Falsified Alert; Drug Products; Regulatory Field Force reported the presence of suspected falsified products in marketOctober 26, 2022
- Drug Impurity Alert ! Compulsory Testing of Solvents Glycerin, Propylene Glycol & Sorbitol used in Oral Preparations for Presence of any Toxic Impurities (e.g. Diethylene Glycol (DEG) & Ethylene Glycol (EG).October 21, 2022
- Recall Alert: Drug Product; Sterile Water for Injection (Batch # 440) By M/s. Karachi Pharmaceutical Laboratories, KarachiOctober 21, 2022
- Usage of online account for DRAP E-services(Pharma industry)October 21, 2022
- Notification: Applications for Registrations of Pharmaceutical drugs submitted on Form 5/5D requiring submission of Product Stability DataOctober 17, 2022
- SRO 1888(I)/2022 : Notification of Clinical Studies Committee under Bio-Study Rules, 2017October 13, 2022
- WHO Global Alert on Contaminated Pediatrics Cough Syrups Identified In Gambia-West AfricaOctober 12, 2022
- Recall Alert: Drug Product; Human Albumin 20% 100mL (Batch/Lot # C236821P02) Manufactured By M/s. Biotest Pharma GmbHOctober 7, 2022
- Recall Alert: Drug Product; Fentos 50mg Tablets (Batch # 599) By M/s. Hisun Pharmaceutical Industries, Gadoon-PakistanOctober 6, 2022
- Recall Alert; Drug Product: Pantoloon 20mg Tablets (Batch # 5611) By M/S. Rock Pharmaceutical Laboratories (Pvt.) Ltd. RisalpurOctober 6, 2022
- Recall Alert; Drug Product: Zatranex 50mg/mL injection (Batch # 622) by M/s. Zafa Pharmaceutical Laboratories (Pvt.) Ltd., Karachi.October 6, 2022
- Decisions of 49th meeting of Medial Device Board (Deficiency letters Local/Import)October 4, 2022
- 110th Meeting of Enlistment Evaluation Committee (EEC); Notice for Submission of Deficient Information / DocumentsSeptember 30, 2022
- 109th Meeting of Enlistment Evaluation Committee (EEC); Notice for Submission of Deficient Information / DocumentsSeptember 30, 2022
- 108th Meeting of Enlistment Evaluation Committee (EEC); Notice for Submission of Deficient Information / DocumentsSeptember 30, 2022
- 107th Meeting of Enlistment Evaluation Committee (EEC); Notice for Submission of Deficient Information / DocumentsSeptember 30, 2022
- DRAP issued Guidelines on Management of High Alert MedicationSeptember 29, 2022
- National Task Force (NTF) for Eradication of Spurious and Unregistered Therapeutic goods; CEO DRAP Chaired the meeting of NTF Core TeamSeptember 29, 2022
- DRAP issued guidance on Remote Virtual Inspection (RVI) for GMP Assessment of overseas manufacturing facilities for registration of finished Pharmaceutical Drugs and BiologicalsSeptember 27, 2022
- Minutes of 320th Meeting of Registration Board held on 29th -31st August, 2022September 26, 2022
- World Patient Safety Day: DRAP takes part in global health campaign on Medication Safety; NPC holds a Webinar on” Medication without Harm” on 16th September, 2022September 16, 2022
- Tender document / terms & conditions for hiring of janitorial services for DRAP head office & NCLB, IslamabadSeptember 16, 2022
- Notification: Expert members of the Medical Device Board (MDB)September 15, 2022
- Auction noticeSeptember 14, 2022
- Asim Rauf, CEO DRAP represented Pakistan in the 2nd Meeting of the Heads of National Medicine Regulatory Authorities (NMRAs) of the Member States of the Organization of Islamic Cooperation, (OIC)September 8, 2022
- Director General, Department of Drug Administration (DDA), Government of Nepal with a delegate visited DRAP HQ to foster mutual cooperationAugust 24, 2022
- National Pharmacovigilance Cell (NPC), DRAP released draft Guidelines on National Pharmacovigilance System (Edition 02) seeking comments from stakeholdersAugust 24, 2022
